50000/Boxes
Biceltis 440mg Injection contains trastuzumab and is used for the treatment of HER2-positive breast cancer. It targets specific proteins on cancer cells to inhibit their growth.
Biceltis Injection Features:
• Targeted therapy for HER2-positive breast cancer.
• Administered intravenously by medical professionals.
• Used in combination with other treatments to improve outcomes.
• Monitored closely for potential side effects.
Minimum Order | 1 |
Copyright © 2024 Shivrupesh Pharma Private Limited All Rights Reserved.